← Return to Manufacturer (Fresenius Kabi) is Out-of-Stock for Tyenne
DiscussionManufacturer (Fresenius Kabi) is Out-of-Stock for Tyenne
Polymyalgia Rheumatica (PMR) | Last Active: Jul 1 12:50pm | Replies (3)Comment receiving replies
Replies to "Does your insurance cover Rinvoq? It is approved for GCA. Unfortunately it can take up to..."
Connect

@jeff97 Well, sort of. According to insurance website, my out-of-pocket for a 90-day supply of Rinvoq would be $21,483.94. But then again, my Rheumatologist has never prescribed Rinvoq for GCA (and would not). I don't recall exactly what she said but even though approved by FDA for GCA (in April 2025), she intimated that it was not widely prescribed in Rheumatology "circles." In any case, Rinvoq is a no-go. Thanks for your comments.